JIN-A02 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-09-30 in 3mo
ESTIMATED |
READOUT
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Pati
Phase 1/2 · EGFR Mutant Advanced Non-small Cell Lung Cancer |
J Ints Bio | JIN-A02 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|